About Renal Denervation Treatment
Renal denervation is a minimally invasive endovascular catheter-based procedure to treat resistant hypertension. Renal denervation treatment is used for hypertension and chronic kidney disease. It uses radiofrequency waves to disrupt the overactive sympathetic nerves running along the arteries in the kidneys. The factors such as Increased Prevalence of Hypertension and Kidney Diseases among People, Increased Number of Diagnostic Centres and Hospitals and Changing Lifestyle of the People are the driving factors for the global renal denervation treatment market.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain competitive advantage through combined collaborations. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
St. Jude Medical (United States), ReCor Medical, Inc. (United States), Boston Scientific (United States), Medtronic (Ireland), Kona Medical, Inc. (United States), Mercator MedSystems, Inc. (United States), Terumo Corporation (Japan) and Abbott Laboratories (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Biosense Webster Inc (United States), Ablative Solutions, Inc. (United States), Theragenics Corporation (United States) and Hansen Medical, Inc. (United States).
Segmentation Overview
AMA Research has segmented the market of Global Renal Denervation Treatment market by , Application (Hospitals, Ambulatory Surgical Centers and Others) and Region.
On the basis of geography, the market of Renal Denervation Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Ultrasound will boost the Renal Denervation Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Diseases, the sub-segment i.e. Hypertension will boost the Renal Denervation Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Growth in the Healthcare Infrastructure in Developing Countries and Cost-Effectiveness of the Procedure
Market Growth Drivers:
Increased Prevalence of Hypertension and Kidney Diseases among People, Increased Number of Diagnostic Centres and Hospitals and Changing Lifestyle of the People
Challenges:
Stringent Government Rules and Regulations
Restraints:
Risks Associated with the Procedure and Less Awareness among People About Treatment
Opportunities:
Growing in the Healthcare Industry Worldwide and Increased Research and Development Activities
Market Leaders and their expansionary development strategies
In November 2023, Spectranetics collaborates with a research institute to investigate the potential of combining renal denervation with other hypertension management strategies.
In December 2023, Spectranetics introduces its Spyzor Max EXC Excimer Laser with enhanced ablation capabilities, aiming for more uniform and durable lesions.
Key Target Audience
Renal Denervation Treatment Providers, Emerging Companies, Research Professionals and End-users
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.